Sittner & Nelson, LLC
- SEC CIK
- 0001846138
- Latest filing
- Aug 7, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Sittner & Nelson, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q2 2026)
- 22,681
- Value
- $2.05M
- % of portfolio
- 0.6%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 22,681 | $2.05M | 0.6% | −1,594−6.6% | Reduced | Holders |
| Q1 2026 | 24,275 | $1.94M | 0.7% | −300−1.2% | Reduced | Holders |
| Q4 2025 | 24,575 | $1.93M | 0.7% | −570−2.3% | Reduced | Holders |
| Q3 2025 | 25,145 | $1.96M | 0.7% | 00.0% | Unchanged | Holders |
| Q2 2025 | 25,145 | $1.97M | 0.8% | 00.0% | Unchanged | Holders |
| Q1 2025 | 25,145 | $1.82M | 0.8% | −200−0.8% | Reduced | Holders |
| Q4 2024 | 25,345 | $1.88M | 0.8% | +600+2.4% | Added | Holders |
| Q3 2024 | 24,745 | $1.63M | 0.7% | +730+3.0% | Added | Holders |
| Q2 2024 | 24,015 | $2.22M | 1.1% | −600−2.4% | Reduced | Holders |
| Q1 2024 | 24,615 | $2.35M | 1.2% | +340+1.4% | Added | Holders |
| Q4 2023 | 24,275 | $1.85M | 1.0% | +550+2.3% | Added | Holders |
| Q3 2023 | 23,725 | $1.64M | 0.9% | −240−1.0% | Reduced | Holders |
| Q2 2023 | 23,965 | $2.26M | 1.2% | 00.0% | Unchanged | Holders |
| Q1 2023 | 23,965 | $1.98M | 1.1% | −300−1.2% | Reduced | Holders |
| Q4 2022 | 24,265 | $1.81M | 1.1% | −400−1.6% | Reduced | Holders |
| Q3 2022 | 24,665 | $2.04M | 1.4% | 00.0% | Unchanged | Holders |
| Q2 2022 | 24,665 | $2.35M | 1.5% | +400+1.6% | Added | Holders |
| Q1 2022 | 24,265 | $2.86M | 1.7% | +1,073+4.6% | Added | Holders |
| Q4 2021 | 23,192 | $3.00M | 1.7% | +127+0.6% | Added | Holders |
| Q3 2021 | 23,065 | $2.61M | 1.7% | 00.0% | Unchanged | Holders |
| Q2 2021 | 23,065 | $2.39M | 1.7% | 00.0% | Unchanged | Holders |
| Q1 2021 | 23,065 | $1.93M | 1.4% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.